Marshall Wace
NVAX icon

Marshall Wace’s Novavax NVAX Stock Holding History

Marshall Wace’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.49M Buy
1,166,197
+236,586
+25% +$2.14M 0.01% 1002
2025
Q4 		$6.25M Buy
929,611
+879,016
+1,737% +$6.63M 0.01% 1060
2025
Q3 		$439K Buy
+50,595
New +$394K ﹤0.01% 2279
2024
Q4 		– Sell
-148,917
Closed -$1.88M – 2876
2024
Q3 		$1.88M Sell
148,917
-213,773
-59% -$2.76M ﹤0.01% 1393
2024
Q2 		$4.59M Buy
+362,690
New +$3.65M 0.01% 1030
2022
Q3 		– Sell
-160,157
Closed -$8.23M – 3659
2022
Q2 		$8.23M Buy
160,157
+143,603
+867% +$7.44M 0.02% 1006
2022
Q1 		$1.22M Sell
16,554
-29,037
-64% -$2.59M ﹤0.01% 2359
2021
Q4 		$6.52M Buy
45,591
+29,731
+187% +$5.11M 0.01% 1170
2021
Q3 		$3.29M Sell
15,860
-25,045
-61% -$5.52M 0.01% 1206
2021
Q2 		$8.68M Sell
40,905
-9,853
-19% -$1.81M 0.04% 548
2021
Q1 		$9.2M Buy
50,758
+47,881
+1,664% +$9.54M 0.04% 497
2020
Q4 		$321K Buy
+2,877
New +$306K ﹤0.01% 1631

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace's NVAX Position: Q1 2026 in Review

Marshall Wace increased its Novavax (NVAX) stake by 25% in Q1 2026, buying an estimated $2.14M and bringing the position to 1,166,197 shares worth $9.49M. The position accounts for 0.01% of the portfolio, ranked #1002.

Marshall Wace first reported a position in NVAX in Q4 2020 and has held it in 12 quarters since. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Marshall Wace held 1,166,197 shares of Novavax worth $9.49M as of Q1 2026.
  • Marshall Wace bought 236,586 Novavax shares in Q1 2026, an estimated $2.14M.
  • Novavax made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1002 holding.
  • Marshall Wace first reported a position in Novavax in Q4 2020 and has held it in 12 quarters since.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.